APTIOM
SUMITOMO PHARMA CANADA, INC.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APTIOM in Canada?
A shortage of APTIOM 400MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated June 30, 2026), but it has not started yet.
Why is APTIOM not available?
The reason the manufacturer reported: Requirements related to complying with good manufacturing practices.
When will APTIOM be available again?
The estimated resolution date (June 30, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
AURO-ESLICARBAZEPINE
AURO PHARMA INC
Other Products
APO-ESLICARBAZEPINE
APOTEX INC
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2026-06-30
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02426870
Strength
400MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
ESLICARBAZEPINE ACETATE
Tier
Unrated
Last Updated
2026-06-30
Reason for Shortage
Requirements related to complying with good manufacturing practices.
Other Products from SUMITOMO PHARMA CANADA, INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.